BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 25057956)

  • 21. The role of the innate immune recognition system in the pathogenesis of primary biliary cirrhosis: a conceptual view.
    Berg PA
    Liver Int; 2011 Aug; 31(7):920-31. PubMed ID: 21733082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary biliary cirrhosis: what do autoantibodies tell us?
    Hu CJ; Zhang FC; Li YZ; Zhang X
    World J Gastroenterol; 2010 Aug; 16(29):3616-29. PubMed ID: 20677333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: diagnostic and prognostic value.
    Muratori L; Granito A; Muratori P; Pappas G; Bianchi FB
    Clin Liver Dis; 2008 May; 12(2):261-76; vii. PubMed ID: 18456179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antinuclear antibodies as ancillary markers in primary biliary cirrhosis.
    Granito A; Muratori P; Quarneti C; Pappas G; Cicola R; Muratori L
    Expert Rev Mol Diagn; 2012 Jan; 12(1):65-74. PubMed ID: 22133120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The epidemiology of primary biliary cirrhosis: immunological problems.
    Uibo R; Salupere V
    Hepatogastroenterology; 1999; 46(30):3048-52. PubMed ID: 10626158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical manifestation and autoantibody profile in 123 patients with primary biliary cirrhosis].
    Liu HH; Fu JL; Xu J; Luo SQ; Liu ZW; Wang FS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):233-7. PubMed ID: 23591343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalence of primary biliary cirrhosis and disease-associated autoantibodies in Japanese patients with systemic sclerosis.
    Imura-Kumada S; Hasegawa M; Matsushita T; Hamaguchi Y; Encabo S; Shums Z; Norman GL; Takehara K; Fujimoto M
    Mod Rheumatol; 2012 Nov; 22(6):892-8. PubMed ID: 22327744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis.
    Agmon-Levin N; Shapira Y; Selmi C; Barzilai O; Ram M; Szyper-Kravitz M; Sella S; Katz BS; Youinou P; Renaudineau Y; Larida B; Invernizzi P; Gershwin ME; Shoenfeld Y
    J Autoimmun; 2010 Feb; 34(1):55-8. PubMed ID: 19897339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis.
    Bandin O; Courvalin JC; Poupon R; Dubel L; Homberg JC; Johanet C
    Hepatology; 1996 May; 23(5):1020-4. PubMed ID: 8621127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormal expression of PDC-E2 on the apical surface of biliary epithelial cells in patients with antimitochondrial antibody-negative primary biliary cirrhosis.
    Tsuneyama K; Van De Water J; Van Thiel D; Coppel R; Ruebner B; Nakanuma Y; Dickson ER; Gershwin ME
    Hepatology; 1995 Nov; 22(5):1440-6. PubMed ID: 7590661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Primary biliary cirrhosis of the liver].
    Popov MS; Popova IV
    Arkh Patol; 1986; 48(5):81-7. PubMed ID: 2427055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimitochondrial Antibody-Negative Primary Biliary Cholangitis: Is It Really the Same Disease?
    Chascsa DM; Lindor KD
    Clin Liver Dis; 2018 Aug; 22(3):589-601. PubMed ID: 30259855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection.
    Bogdanos DP; Baum H; Butler P; Rigopoulou EI; Davies ET; Ma Y; Burroughs AK; Vergani D
    Dig Liver Dis; 2003 Nov; 35(11):801-5. PubMed ID: 14674671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical expression of primary biliary cirrhosis.
    Heathcote J
    Semin Liver Dis; 1997 Feb; 17(1):23-33. PubMed ID: 9089908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased expression of nuclear envelope gp210 antigen in small bile ducts in primary biliary cirrhosis.
    Nakamura M; Takii Y; Ito M; Komori A; Yokoyama T; Shimizu-Yoshida Y; Koyabu M; Matsuyama M; Mori T; Kamihira T; Daikoku M; Migita K; Yatsuhashi H; Nozaki N; Shimoda S; Ishibashi H
    J Autoimmun; 2006 Mar; 26(2):138-45. PubMed ID: 16337775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meta-analysis assessment of GP210 and SP100 for the diagnosis of primary biliary cirrhosis.
    Hu SL; Zhao FR; Hu Q; Chen WX
    PLoS One; 2014; 9(7):e101916. PubMed ID: 25010534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small ubiquitin-related modifiers: A novel and independent class of autoantigens in primary biliary cirrhosis.
    Janka C; Selmi C; Gershwin ME; Will H; Sternsdorf T
    Hepatology; 2005 Mar; 41(3):609-16. PubMed ID: 15726652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimitochondrial antibodies in primary biliary cirrhosis: the role of xenobiotics.
    Long SA; Van de Water J; Gershwin ME
    Autoimmun Rev; 2002 Feb; 1(1-2):37-42. PubMed ID: 12849056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antinuclear antibodies in primary biliary cirrhosis.
    Invernizzi P; Selmi C; Ranftler C; Podda M; Wesierska-Gadek J
    Semin Liver Dis; 2005 Aug; 25(3):298-310. PubMed ID: 16143945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of autoantibodies against components of the nuclear pore complexes: high frequency of anti-p62 nucleoporin antibodies.
    Wesierska-Gadek J; Klima A; Komina O; Ranftler C; Invernizzi P; Penner E
    Ann N Y Acad Sci; 2007 Aug; 1109():519-30. PubMed ID: 17785341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.